Full Length Research Paper
References
|
Badmaev V, Prakash S, Majeed M (1999). Vanadium: a review of its potential role in the fight against diabetes. J. Altern. Complementary Med. 5(3):273-291. |
|
|
Battell M, Yuen V, McNeill J (1992). Treatment of BB rats with vanadyl sulfate. Pharmacol. Commun. 1:291-301. |
|
|
Beyegue CFN, Ngangoum RMC, Kuate D, Ngondi JL, Oben JE (2012). Effect of Guibourtia tessmannii extracts on blood lipids and oxidative stress markers in triton WR 1339 and high fat diet induced hyperlipidemic rats. Biol. Med. 4(1):1-9. |
|
|
Bhatnagar D, Soran H, Durrington PN (2008). Hypercholesterolaemia and its management. Bmj. 337:a993. |
|
|
Buchwald H, Campos CT, Boen JR, Nguyen PA, Williams SE (1995). Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH). J. Am. Coll. Cardiol. 26(2):351-357. |
|
|
Burstein M, Scholnick HF, Morfin R (1970). Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11(6):583-593. |
|
|
Cam M, Faun J, McNeill J (1995). Concentration-dependent glucose-lowering effects of oral vanadyl are maintained following treatment withdrawal in streptozotocin-diabetic rats. Metabolism 44:332-339. |
|
|
Chen WY, Chen CJ, Liu CH, Mao FC (2010). Chromium attenuates high-fat diet-induced non-alcoholic fatty liver disease in KK/HlJ mice. Biochem. Biophy. Res. Commun. 397(3):459-464. |
|
|
Corsini A, Raiteri M, Soma MR, Gabbiani G, Paoletti R (1992). Simvastatin but not pravastatin has a direct inhibitory effect on rat and human myocyte proliferation. Clin. Biochem. 25(5):399-400. |
|
|
Costa Pessoa J (2015). Thirty years through vanadium chemistry. J. Inorg. Biochem. 147:4-24. |
|
|
Deborah A, Smith SM, Winter P, Zhou J, Dou P, Baruah B, Trujillo AM, Levinger NE, Yang X, Barisas BG, Crans DC (2008). Effects of Vanadiumâ€Containing Compounds on Membrane Lipids and on Microdomains Used in Receptorâ€Mediated Signaling. Chem. Biodivers. 5(8):1558-1570. |
|
|
Demacker PN, Hijmans AG, Vos-Janssen HE, van't Laar A, Jansen AP (1980). A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin. Chem. 26(13):1775-1779. |
|
|
Elisavet M, Evangelos NL, Constantinos CT, Haralambos JM, Alexandros DT, Moses SE (2013). Comparison of the effect of simvastatin versus simvastatin/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia. Atherosclerosis 231(1):8-14. |
|
|
Fiala S, Fiala AE, Dixon B (1972). γ-Glutamyl transpeptidase in transplantable, chemically induced rat hepatomas and spontaneous mouse hepatomas. J. Nat. Cancer. Inst. 48(5):1393-1401. |
|
|
Gail RW, Lai-Har C, Michael G, Paul JK, Jason JS, Alejandro MT, Josephine AA, Wenjin D, Zihua H, Debbie CC (2011). Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes. Coord. Chem. Rev. 255(19):2258-2269. |
|
|
Garribba E, Santos MF, Santos-Silva T (2015). Vanadium and proteins: uptake, transport, structure, activity and function. Coord. Chem. Rev. 301:49-86. |
|
|
IMS Health (2012). US Top Ten Products by Prescriptions Source: IMS HEALTH, National Prescription Audit PlusTM. Available at: http://www.imshealth.com/en/about-us/news/top-line-market-data# |
|
|
Kind RPN, King EJ (1954). Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J. Clin. Path. 7:332-336. |
|
|
Kong WJ, Liu J, Jiang JD (2006). Human low-density lipoprotein receptor gene and its regulation. J. Mol. Med. 84:29-36. |
|
|
Lecarpentier E, Morel O, Fournier T, Elefant E, Chavatte-Palmer P, Tsatsaris V (2012). Statins and pregnancy: Between supposed risks and theoretical benefits. Drugs 72(6):773-788. |
|
|
Liu J, Cui H, Liu X, Peng X, Deng J, Zuo Z, Wang K (2012). Dietary high vanadium causes oxidative damage-induced renal and hepatic toxicity in broilers. Biol. Trace Elem. Res. 145(2):189-200. |
|
|
Lowell BF, Ralph TD (1973). Stable reagents for determination of serum triglycerides by a colorimetric hantzsch condensation method. Clin. Chem. 19(3):338-340. |
|
|
Mahmoud KE, Shalahmetova T, Deraz S, Umbayev B (2011). Combined effect of vanadium and nickel on lipid peroxidation and selected parameters of antioxidant system in liver and kidney of male rat. Afr. J. Biotechnol. 10(79):18319-18325. |
|
|
Mancini GB, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, Gupta M, Hegele RA, Ng D, Pope J (2011). Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference. Can. J. Cardiol. 27:635-662. |
|
|
McKenney JM (2003). Pharmacologic characteristics of statins. Clin. Cardiol. 26(S3):32-38. |
|
|
Meyerovitch J, Rothenberg P, Shecter Y, Bonner-Weir S, Kahn R (1991). Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus. J. Clin. Invest. 87(4):1286-1294. |
|
|
Mingxia X, Deliang C, Fang Z, Gail RW, Debbie CC, Wenjun D (2014). Effects of vanadium (III, IV, V)-chlorodipicolinate on glycolysis and antioxidant status in the liver of STZ-induced diabetic rats. J. Inorg. Biochem. 136:47-56. |
|
|
Ness GC, Zhao Z, Lopez D (1996). Inhibitors of cholesterol biosynthesis increase hepatic low density lipoprotein receptor protein degradation. Arch. Biochem. Biophys. 325:242-248. |
|
|
Pugazhenti S, Angel J, Khandelwal R (1991). Long-term effects of vanadate treatment on glycogen metabolism and lipogenic enzymes of liver in genetically diabetic (db/db) mice. Metabolism 40(9):941-946. |
|
|
Raedsch R, Stiehl A, Gundert-Remy U, Walker S, Sieg A, Czygan P, Kommerell B (1983). Hepatic Secretion of Bilirubin and Biliary Lipids in Patients with Alcoholic Cirrhosis of the Liver. Digestion 26(2):80-88. |
|
|
Reitman S, Frankel S (1957). A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 28(1):56-63. |
|
|
Sanchez C, Torres M, Bermudez-Pena MC, Aranada P, Montes-Bayon M, Sanz-Medel A, LIopis J (2011). Bioavailability, tissue distribution and hypoglycemic effect of vanadium in magnesium-deficient rats. Magnes. Res. 24(4):196-208. |
|
|
Schaalan M, El-Abhar HS, Barakat M, El-Denshary ES (2008). Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride. J. Diabet. Complications 23(3):199-208. |
|
|
Shechter Y, Shisheva A (1993). Vanadium salts and the future treatment of diabetes. Endeavour 17:27-31. |
|
|
Soveid M, Dehghani GA, Omrani GR (2013). Long-term efficacy and safety of vanadium in the treatment of type 1 diabetes. Arch Iran Med. 16(7):408-4011. |
|
|
Stohs SJ, Bagchi D (1995). Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol. Med. 18(2):321-326. |
|
|
Subramanian IP, Sorimuthu PS, Muthusamy K (2014). Antidyslipidemic effect of a novel vanadium-3-hydroxy flavone complex in streptozotocin-induced experimental diabetes in rats. Biomed. Prevent. Nutr. 4(2):189-193. |
|
|
Vallim T, Salter AM (2010). Regulation of hepatic gene expression by saturated fatty acids. Prostaglandins, Leukot. Essent. Fatty Acids 82(4):211-218. |
|
|
Vaughan CJ, Murphy MB, Buckley BM (1996). Statins do more than just lower cholesterol. Lancet 348:1079-1082. |
|
|
Verma S, Cam M, McNeill J (1998). Nutritional factors that can favorably influence the glucose/insulin system: vanadium. J. Am. College. Nutr. 17(1):11-18. |
|
|
Yong JY, Hyo JK, Sang KJ, Sung GK, Young RS, Wookyung C, Kum HH, Chang HL, Young-Hwan H, Kook-Hwan O (2014). Comparison of the Efficacy and Safety Profile of Morning Administration of Controlled-release Simvastatin Versus Evening Administration of Immediate-release Simvastatin in Chronic Kidney Disease Patients with Dyslipidemia. Clin. Therapeut. 36(8):1182-1190. |
|
|
Yuen V, Orvig C, Mcneill J (1995). Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Can. J. Physiol. Pharmacol. 73(1):55-64. |
|
|
Zhang S, Zheng L, Dong D, Xu L, Yin L, Qi Y, Han X, Lin Y, Liu K, Peng J (2013). Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats. Food Chem. 141(3):2108-2116. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
